info@sheller.com • PA:215-790-7300 • NJ:609-941-2596
800-883-2299
 

News & Media

IN THE NEWS: Media coverage and video of Sheller, P.C. Risperdal lawsuit settlements; Sheller represents hundreds of boys in J&J Risperdal breast growth litigation

2014-01-15 -

J&J settles a total of six lawsuits with Sheller, P.C. clients; hundreds more represented

News Coverage:

Risperdal Suit Filings Increase in Phila. Court, The Legal Intelligencer, January 15, 2014

Lawyer Spars with FDA over J&J Risperdal Court Documents, Pharmalot, November 11, 2013 (Attorney Stephen Sheller's strategy to hold J&J accountable profiled in pharmaceutical industry news)

University Researchers Are Seen As Enablers in Latest Drug Fraud, The Chronicle of Higher Education, November 8, 2013 (quotes Attorney Stephen Sheller saying the research gave a 'misleading impression of the actual risk of breast development in boys)

J&J Balks on Deal to Settle U.S. Probe, The Wall Street Journal, May 9, 2013 (quotes Attorney Stephen Sheller on lawsuits involving boys and young men who developed gynecomastia while taking Risperdal)

Six Risperdal Suits to See Appeal Over Marketer's Dismissal, Law360/LexisNexis, November 16, 2012 (requires subscription, see text here)

Johnson & Johnson settles six Risperdal boy breas tlawsuits, hundreds of cases pending, CBS Moneywatch (PR Web distribution), October 10, 2012

Johnson & Johnson settles five Risperdal suits, The Philadelphia Inquirer, October 5, 2012

First Risperdal Trial Ends with Settlement, six cases total have settled in the litigation, The Legal Intelligencer, October 5, 2012 (PDF of newspaper)

J&J resolves 5 Risperdal off-label cases, Law360/LexisNexis, October 4, 2012

Johnson & Johnson agrees to settle five Risperdal suits, Bloomberg Business Week, October 4, 2012

Former FDA Commish slams J&J over Risperdal, Pharmalot, October 4, 2012

J&J aims to block ex-FDA chief's testimony in Risperdal case, Fierce Pharma, October 4, 2012

Ex-FDA chief David Kessler says J&J broke the law in promoting Risperdal, The Philadelphia Inquirer's "PhillyPharma" blog, October 4, 2012

Lawsuit: Risperdal Schizophrenia Drug Makes Boys Grow Breasts, Law.com blog, October 2, 2012

Products liability trial in Risperdal case opens, Pittsburgh Post-Gazette/The Legal Intelligencer, October 1, 2012

Psychiatrist, plaintiff's expert witness, testifies on third day of Philadelphia Risperdal trial, The Pennsylvania Record, Pennsylvania's Legal Journal, September 28, 2012

Mother asks judge to release J&J report, wants jurors to see, The Philadelphia Inquirer, September 28, 2012

'Risperdal Popcorn' - Part of Day 2 of Philly Trial, The Philadelphia Inquirer's "PhillyPharma" blog, September 26, 2012

Witness: J&J aimed Risperdal pitch at childrens' doctors, Fierce Pharma, September 26, 2012

Products liability trial in Risperdal case opens in Philadelphia, The Legal Intelligencer, September 25, 2012 (PDF of newspaper)

Janssen promoted Risperdal off label, jury hears, Law360/LexisNexis, September 25, 2012

J&J pushed Risperdal with golf, popcorn, witness says, Bloomberg News, September 25, 2012

Risperdal trial: Sales rep cites pressure from above, The Philadelphia Inquirer, September 25, 2012

J&J lawyers to jury: What Risperdal popcorn?, Pharmalot, September 25, 2012

Risperdal caused teen boy's breast growth, jury hears, Law360/LexisNexis, September 24, 2012

Chasing the press out of the room? A Q&A with Philadelphia Inquirer David Sell about his experience with J&J lawyers attempting to remove him from Risperdal trial jury selection, Pharmalot, September 21, 2012

Philly judge stops J&J attempt to bar Inquirer reporter, The Philadelphia Inquirer's "PhillyPharma" blog, September 21, 2012

Johnson & Johnson CEO will not have to testify in Risperdal drug case, The Philadelphia Inquirer & Bloomberg Business Week, September 21, 2012

J&J's Alex Gorsky testify? Much too busy . . . on the other side of the planet, The Philladelphia Inquirer's "PhillyPharma" blog, September 19, 2012

Lawyers seek to force J&J chief onto the stand in Risperdal case, Fierce Pharma, September 19, 2012

Risperdal mass tort case settles in Phila. on first day of trial, The Pennsylvania Record, Pennsylvania's Legal Journal, September 19, 2012

J&J's CEO Should Be Forced to Testify, Teen's Lawyers Say, Bloomberg, September 18, 2012

Lawyers in Risperdal case argue Johnson & Johnson's CEO should be called to testify, Asbury Park Press/NJ.com, September 18, 2012

Lawyers for Teen Boy Say J&J CEO Should Be Forced to Testify, Pharmalot, September 18, 2012

Attys Want J&J CEO to Testify in Risperdal Breast Growth Case, Law360/LexisNexis, September 18, 2012

J&J CEO Gorsky talks Risperdal, via deposition, with lawyers nearby, The Philladelphia Inquirer's "PhillyPharma" blog, September 19, 2012

J&J Settles Suit Over Risperdal and Male Breasts, PharmaLot.com, September 11, 2012

Johnson and Johnson settles Risperdal side effects lawsuit, The Philadelphia Inquirer, September 11, 2012

J&J settles Risperdal male breasts case on first day
, Pharma Times Online, September 11, 2012

J&J Sees Male Breasts and Quickly Settles Risperdal Suit, Forbes, September 11, 2012

J&J Settles Risperdal Lawsuit on Opening Day of Trial, Bloomberg Business Week, September 10, 2012

Johnson & Johnson settles on first day of Philly Risperdal trial
, The Philladelphia Inquirer & "PhillyPharma" blog, September 10, 2012

J&J Settles Lawsuit Alleging Injury from Antipsychotic, The Wall Street Journal/Dow Jones Newswire, September 10, 2012

J&J Settles PA Risperdal Lawsuit on Opening Day of Trial, Law 360/LexisNexis, September 10, 2012

J&J settles after plaintiff says drug caused him to grow breast tissue, Asbury Park Press, September 10, 2012
 


Top Stories

Sheller Whistleblower Team: $7.3M Astellas Pharma Off-Label Marketing and FCA Settlement

IN THE NEWS: Stephen Sheller Quoted in "Low T Drug Cases Could Be Next MDL, Mass Tort"

Sheller Whistleblower False Claims Act Settlement: Florida Pain Practice Agrees to Pay Government $750,000 
to Settle Allegations of Unperformed Procedures Billed to Medicare

SHELLER FOUNDATION NEWS: Drexel's 11th Street Health Center to Expand; Sheller Gift Supports Center's Mission

IN THE NEWS: Media coverage and video of Sheller, P.C. Risperdal lawsuit settlements; Sheller represents hundreds of boys in J&J Risperdal breast growth litigation

IN THE NEWS: Stephen Sheller Quoted in Bloomberg Business Week on Whistleblowers and the Firm's Recent J&J $2.2B Settlement

NEWS: J&J to Pay at Least $2.5 Billion to Settle Hip Lawsuits

IN THE NEWS: Researchers Backpedal From Their Own Risperdal Study

IN THE NEWS: Sheller, P.C. in the Chronicle of Higher Education "University Researchers Are Seen as Enablers in Latest Major Drug Fraud"

IN THE NEWS: Sheller, P.C. in Philadelphia Inquirer "J&J to pay $2.2B for Improper Promotion of Risperdal"

NEWS: Whistleblower Law Firm Sheller, P.C. Announces $2+ Billion Johnson & Johnson Risperdal Illegal Marketing Civil and Criminal Settlement, Largest for Single Drug in U.S. History

IN THE NEWS: The Pennsylvania Record reports that Sheller attorneys have filed an additional Risperdal case on behalf of Texas client

IN THE NEWS: Sheller Whistleblower UMass medical billing fraud case settles for 66k

NEWS: OIG Medicare/Medicaid Whistleblower Fraud Alert and WSJ story on Physician-owned distributorships (PODs) of medical devices

IN THE NEWS: Attorney Stephen Sheller "Lawyer Spars With FDA Over J&J Risperdal Court Documents"

IN THE NEWS: Stephen Sheller in Philadelphia Inquirer "FDA Slow to Ask J&J for Drug Data"

IN THE NEWS: Stephen A. Sheller, founding partner of Sheller, P.C., was quoted in the The Philadelphia Inquirer article "High Court Sides with Philadelphia Drug Firm"

NEWS: Lipitor May Increase Diabetes Risk

NEWS: FDA Investigates Two Deaths in Zyprexa Patients

IN THE NEWS: Attorney Stephen Sheller Featured Television Panelist Discussing FDA and Pharma Executives, The American Law Journal

NEWS: Dispute Flares Inside FDA Over Safety of Popular Blood-Pressure Drugs

NEWS: SuperLawyers 2013: Seven Sheller, P.C. Attorneys honored, Stephen Sheller for 10th straight year

NEWS: Study of Babies Did Not Disclose Risks, U.S. Finds; Sheller Attorneys Investigating on Behalf of Families

NEWS: NFL & Players Have Their First Day in Court

IN THE NEWS: Sheller, P.C. Settlement Featured in The Legal Intelligencer "Top 10" since 1994

NEWS: Regulator Issues Fraud Alert on Doctor-Owned Distributors

IN THE NEWS: "Justice for All" in the Temple Times newspaper: Sheller Center for Social Justice

NEWS: Sheller Family Foundation Gift Establishes Social Justice Center at Temple University Beasley School of Law

NEWS: Health Care Fraud Cases Yield $4.2 billion

NEWS: Shire agrees to settle ADHD drug inquiry

NEWS: Court says Pfizer can be sued by man who took generic drug

IN THE NEWS: Stephen Sheller quoted in Forbes.com "Will A Court Ruling Usher In Off-Label Promotions?"

IN THE NEWS: Stephen Sheller quoted in Philadelphia Inquirer article "Court Ruling Could Grant Latitude on Drug Claims"

IN THE NEWS: Stephen Sheller profiled in Philadelphia Life Magazine

IN THE NEWS: Sheller Risperdal settlements front page of The Legal Intelligencer

NEWS: Sheller attorneys investigate reports of Allergan Lap-Band injuries and deaths

NEWS: Sheller Client's Mother Asks Judge in Risperdal Trial to Release J&J Report for Jurors

SPEAKER: Attorney Jamie Sheller to present hip implant litigation strategies

IN THE NEWS: Sheller Products Liability Trial in Risperdal Case Opens in Phila.

NEWS: Sheller, P.C. filing center of Bloomberg article "J&J CEO Should Be Forced to Testify Teens Lawyers Say"

NEWS: J&J Settles with Sheller, P.C. client on first day of Risperdal jury trial

IN THE NEWS: Sheller, P.C. profiled in Suburban Life magazine

NEWS: Stephen Sheller quoted by Pharma Gossip Blog on Off-Label Marketing of Drugs

SPEAKER: Attorney Jamie Sheller Featured Speaker at Annual NetDiligence Cyber Risk and Privacy Liability Forum

SPEAKER: Attorney Jamie Sheller presented at the PBI conference "How to Properly Document Settlement Agreements"

NEWS: Sheller, P.C. Attorneys Honored Again in 2012 as SuperLawyers®

LEGAL PUBLICATIONS NEWS: Sheller, P.C. #1 settlement in Pennsylvania, 2010

IN THE NEWS: Stephen Sheller Quoted on Arkansas Risperdal $1.2B verdict in Gannett and Philadelphia Newspapers

NEWS: J&J's Marketing of Risperdal Violated Law, Arkansas Jury Rules, $1.1B Penalty

NEWS: Generic Drugs Proving Resistant to Damage Suits

NEWS: Philadelphia Trial Lawyers Ask First Judicial District to Rethink Mass Torts Rules

IN THE NEWS: Attorney Jamie Sheller Quoted in Lawyers.com Article on Paula Abdul Slip and Fall Lawsuit

NEWS: J&J to Pay $158M in Risperdal Case; Sheller Quoted on Mass Tort Litigation

NEWS: J&J Pushed Risperdal for Kids Without Approval, Memo Shows

NEWS: J&J Opposes Texas in $1 Billion Risperdal Marketing Trial

NEWS: J&J Said to Agree to $1B in Risperdal Marketing Probe

IN THE NEWS: Attorney Stephen Sheller comments on the potential legal issues in the Penn State sexual abuse allegations

NEWS: Sheller, P.C. releases new video series, "What Is a Whistleblower Claim?"

IN THE NEWS: Sheller 'Live Stop' Class Action, Story of Sheller Client in the Philadelphia Daily News

IN THE NEWS: Attorney Jamie Sheller Quoted by Business Insurance on Data Breach Issues

NEWS: Sheller, P.C. Files Lawsuits Over Police 'Live Stop' Tactics

WHISTLEBLOWER WEBINAR: Attorney Stephen Sheller presented LexisNexis program

NEWS: Sheller, P.C. Attorneys Recognized as 2011 SuperLawyers®

IN THE NEWS: Attorney Stephen Sheller Interviewed by FOX on 'Live Stop' Traffic Enforcement Class Action

NEWS: Attorney Stephen Sheller files suit claiming Philly cops use 'live stop' statute to seize cars illegally

NEWS: Jury Finds Risperdal Manufacturer Violated Consumer Laws; Sheller Attorneys Continue to Pursue Justice for Injured Children

TEMPLE U. LAW SCHOOL ROSS MEMORIAL LECTURE: Stephen Sheller Presents Lecture

NEWS: Attorney Stephen Sheller Honored With First "Pioneer" Award at AAJ Conference

NEWS: Sheller Attorneys Win Class Cert. in 'Light' Tobacco, Potential Actual Damages of Billions for Consumers in Minnesota

NEWS: Jamie Sheller is Featured Presenter at DePuy Hip Implant Recall Litigation Conference, November 3, 2010

NEWS: Stephen Sheller quoted in New York Times article "Side Effects May Include Lawsuits"

IN THE COMMUNITY: Stephen Sheller throws first pitch at Philadelphia Phillies

IN THE COMMUNITY: Stephen Sheller Honored by U.S. Commanding General for Iraq for Dedication to PA National Guard

NEWS: Jamie Sheller in Law.com and Legal Intelligencer on Paxil Birth Defects Cases

NEWS: Pennsylvania Higher Education Foundation Announces Sheller Scholarships

NEWS: Sheller, P.C. attorneys honored once again as SuperLawyers®, 2010

NEWS: Shellers Sponsor Pennsylvania National Guard Exhibit at the National Liberty Museum

NEWS: $520 Million Brings Total Sheller Pharma Whistleblower Settlements to $4.2 Billion

CONSUMER ALERT: Sheller, P.C. Attorneys investigating injuries from recalled Nissan vehicles

CONSUMER ALERT: Sheller, P.C. investigating injuries reported by drivers of Toyotas, concern mounts over accidents in models not listed in recall

NEWS: Stephen Sheller quoted on front page of San Francisco Chronicle

NEWS: Stephen Sheller quoted in Legal Intelligencer story about Toyota litigation

NEWS: Jamie Sheller interviewed in The Philadelphia Inquirer about her client injured by MTD Snowthrower

NEWS UPDATE Toyota Recall: Sheller, P.C. Filing National Class Action Against Toyota

NEWS: Stephen Sheller interviewed on WHYY about Whistleblower/False Claims Act cases

NEWS: New Paxil Birth Defects Cases

NEWS UPDATE: Sheller plans filing twenty to thirty more Risperdal/ Invega cases

NEWS: Sheller, P.C. Files Lawsuits Against Manufacturers of Antipsychotic Drugs Risperdal and Invega

CONSUMER ALERT: Recalled Flu Vaccine Prompts Sheller, P.C. Investigation

NEWS: Sheller, P.C. attorney Jamie Sheller appears on special broadcast of The American Law Journal

IN THE COMMUNITY: Shellers honored at National Philanthropy Day Awards

VERDICT: Jamie Sheller represents client in $2.5 million Paxil birth defects verdict

VERDICT: Sheller, P.C. Whistleblower Case: $2.3 Billion Settlement

VERDICT: Sheller, P.C. Whistleblower Case: $1.4 Billion Settlement

CONSUMER ALERT: Is there a link between antidepressants and Autism?


Links / Associations